High-Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin Lymphoma in Children

High-dose chemotherapy and stem cell transplant is not used as the first treatment for non-Hodgkin lymphoma (NHL) in children, but a transplant may be an option if the first treatment does not work or if the lymphoma comes back after treatment.

The doses of chemotherapy (chemo) drugs normally are limited by the side effects these drugs can cause. Higher doses can’t be used, even if they might kill more cancer cells, because they would severely damage the bone marrow, where new blood cells are made. 

A stem cell transplant (also known as a bone marrow transplant) lets doctors give higher doses of chemotherapy (sometimes along with radiation therapy). This is because after getting high-dose chemo treatment, the child gets a transplant of blood-forming stem cells to restore the bone marrow. The blood-forming stem cells used for a transplant can come either from the blood or from the bone marrow.

Types of transplants

There are 2 main types of stem cell transplants (SCTs), based on the source of the stem cells. 

  • In an autologous stem cell transplant, the child’s own stem cells are used. They are collected several times in the weeks before treatment. The cells are frozen and stored while the child gets treatment (high-dose chemo and/or radiation), and then are given back into the child’s blood by an IV.
  • In an allogeneic stem cell transplant, the stem cells come from someone else (a donor). Usually this is a brother or sister, although the source may be another donor or even umbilical cord blood. The donor’s tissue type (also known as the HLA type) needs to match the child’s tissue type as closely as possible to help prevent the risk of major problems with the transplant. Regardless of the source, the stem cells are frozen and stored until they are needed for the transplant.

Autologous SCTs are used more often than allogeneic SCTs to treat lymphoma in children. Still, using the child’s own stem cells may not be an option if the lymphoma has spread to the bone marrow. If that occurs, it may be hard to get a stem cell sample that is free of lymphoma cells. 

The use of allogeneic transplants is limited in treating lymphoma because they can have severe side effects that make them hard to tolerate. It can also be hard to find a matched donor. 

A stem cell transplant is a complex treatment that can cause serious, possibly even life-threatening side effects. If your child’s doctors think he or she might benefit from a transplant, it should be done at a center where the staff has experience with the procedure and with managing the recovery phase.

If your child's canacer care team suggests a stem cell transplant, be sure to talk to them beforehand to learn about possible long-term effects your child may have. More information on possible long-term effects can be found in Late and Long-term Effects of Treatment for Non-Hodgkin Lymphoma in Children.

To learn more about stem cell transplants, including how they are done and their potential side effects, see Stem Cell Transplant for Cancer.

The American Cancer Society medical and editorial content team
Our team is made up of doctors and master’s-prepared nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.

Allen CE, Kamdar KY, Bollard CM, Gross TG. Malignant non-Hodgkin lymphomas in children. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 7th ed. Philadelphia Pa: Lippincott Williams & Wilkins; 2016:587–603.

Kamdar KY, Sandlund JT, Bollard CM. Malignant lymphomas in childhood. In: Hoffman R, Benz EJ, Silberstein LE, Heslop HE, Weitz JI, Anastasi J, eds. Hematology: Basic Principles and Practice. 6th ed. Philadelphia, Pa: Elsevier; 2013:1255−1266.

National Cancer Institute Physician Data Query (PDQ). Childhood Non-Hodgkin Lymphoma Treatment. 2016. Accessed at www.cancer.gov/types/lymphoma/hp/child-nhl-treatment-pdq on June 8, 2017.

Rabin KR, Margolin JF, Kamdar KY, Poplack DG. Leukemias and lymphomas of childhood. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2015:1500–1510.

Sandlund JT, Onciu M. Childhood lymphoma. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia, Pa: Elsevier; 2014:1873–1889.

Last Medical Review: June 20, 2017 Last Revised: August 4, 2017

American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.